ConductScience.org, home

Paper41301418

Understanding Atopic Dermatitis: Pathophysiology and Management Strategies.

Chai H and 3 others. Biomolecules, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Understanding Atopic Dermatitis: Pathophysiology and Management Strategies. Papers, record 41301418. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301418

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Understanding Atopic Dermatitis: Pathophysiology and Management Strategies.
PubMed
Journal
Biomolecules
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.52, provisional
iCite
Revised in PubMed
2026-03-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chai HHeng
2Siu WSWing Sumhttps://orcid.org/0000-0002-2791-7121
3Ma HHuihttps://orcid.org/0000-0003-2942-597X
4Li YYuzhen

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dermatitis, AtopicMajor topic
Humans
Quality of Life
Disease Management

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132738956Atopic dermatitis.Lancet2020https://conductscience.org/library/papers/32738956PubMed
236428493Atopic Dermatitis: Clinical Aspects and Unmet Needs.Biomedicines2022https://conductscience.org/library/papers/36428493PubMed
338258428Clinical features and biomarker differences of severe intrinsic and extrinsic atopic dermatitis.Cutan Ocul Toxicol2024https://conductscience.org/library/papers/38258428PubMed
436736457Oral Janus kinase inhibitors for atopic dermatitis.Ann Allergy Asthma Immunol2023https://conductscience.org/library/papers/36736457PubMed
528978208Overview of atopic dermatitis.Am J Manag Care2017https://conductscience.org/library/papers/28978208PubMed
636509097An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study.Lancet2023https://conductscience.org/library/papers/36509097PubMed
740085349Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years.Am J Clin Dermatol2025https://conductscience.org/library/papers/40085349PubMed
837376976Identification of novel mutations in patients with Diamond-Blackfan anemia and literature review of RPS10 and RPS26 mutations.Int J Lab Hematol2023https://conductscience.org/library/papers/37376976PubMed
933000503
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
Br J Dermatol2021https://conductscience.org/library/papers/33000503PubMed
1034631601The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34631601PubMed
1127272078Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.J Drugs Dermatol2016https://conductscience.org/library/papers/27272078PubMed
1232819567Social defeat stress exacerbates atopic dermatitis through downregulation of DNA methyltransferase 1 and upregulation of C-C motif chemokine receptor 7 in skin dendritic cells.Biochem Biophys Res Commun2020https://conductscience.org/library/papers/32819567PubMed
1331474543Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.J Allergy Clin Immunol Pract2020https://conductscience.org/library/papers/31474543PubMed
1434842931The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support.Acta Derm Venereol2021https://conductscience.org/library/papers/34842931PubMed
1530970204Crisaborole 2% Ointment (Eucrisa) for Atopic DermatitisSkin Therapy Lett2019https://conductscience.org/library/papers/30970204PubMed
1620647212Genomewide association studies and assessment of the risk of disease.N Engl J Med2010https://conductscience.org/library/papers/20647212PubMed
1734344611Subtypes of atopic dermatitis: From phenotype to endotype.Allergol Int2022https://conductscience.org/library/papers/34344611PubMed
1834045488Contact dermatitis.Nat Rev Dis Primers2021https://conductscience.org/library/papers/34045488PubMed
1937943240Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.J Am Acad Dermatol2024https://conductscience.org/library/papers/37943240PubMed
2028485036
Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
Br J Dermatol2017https://conductscience.org/library/papers/28485036PubMed

See all 90 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42604213Factors Influencing Self-Management Behaviors in Patients with Atopic Dermatitis and Intervention Strategies: A Narrative Review.Patient Prefer Adherence2026https://conductscience.org/library/papers/42604213PubMed
42514070Atopic Dermatitis Beyond Cutaneous Inflammation: The Interplay Between Progesterone, Testosterone, Gut Microbiota, and Immune Dysregulation.Microorganisms2026https://conductscience.org/library/papers/42514070PubMed
42329514Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.Am J Clin Dermatol2026https://conductscience.org/library/papers/42329514PubMed
42133244Aeroallergens in Atopic Dermatitis and Chronic Urticaria.Curr Allergy Asthma Rep2026https://conductscience.org/library/papers/42133244PubMed
42094859Effectiveness of Abrocitinib in Atopic Dermatitis Presenting with Hand-Foot Eczema and Nail Dystrophy: A Case Report.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/42094859PubMed
41682248Psychological Distress and Quality of Life in a Community-Based Sample of Adults with Atopic Dermatitis: A Cross-Sectional Exploratory Study.Healthcare (Basel)2026https://conductscience.org/library/papers/41682248PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301418

GET https://conductscience.org/api/papers/v1/41301418/references?page=2